Sweden · Delayed Price · Currency is SEK Freemelt Holding AB Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 162% year-over-year, with strong momentum in MedTech, defense, and fusion sectors. A SEK 36 million warrant issue will fund commercialization and scaling, targeting a EUR 41–51 billion market. Tungsten part production starts in Gothenburg, with global expansion planned.
-
Revenue more than doubled year-over-year in Q1, driven by strong operational progress and strategic customer projects. Gross margin reached 57% due to a favorable sales mix, and the company remains focused on scaling through a hybrid business model and expanding in fusion and defense sectors.
Fiscal Year 2025
-
Record 2025 sales grew 172% year-over-year, driven by strong machine demand and strategic partnerships. Outsourcing production and new financing improved scalability and reduced risk, while the company is well-positioned for growth in medtech, defense, and energy sectors.
-
Q3 delivered record order intake and sales, with a 228% year-to-date order growth and 128% net sales increase. Strategic expansion into China and outsourcing to Scanfil support future growth, while margins are expected to improve as production efficiencies rise.
-
A differentiated, modular approach in additive manufacturing is driving growth across defense, energy, and medtech, with record sales and strategic expansion into China. Fusion energy projects highlight the value of AM tungsten components, while medtech adoption and financial stability support a positive outlook.
-
Q2 2025 saw record sales of SEK 19 million, matching the prior full year, with strong order intake and strategic milestones including entry into China and outsourcing manufacturing. Growth in defense, energy, and MedTech sectors, alongside a rising installed base, positions the company for continued expansion.
-
Q1 2025 saw record order book growth, driven by strong demand in defense and energy, despite no machine deliveries and negative operating cash flow. A successful rights issue raised SEK 90 million, and new strategic projects in fusion energy and defense were secured.
Fiscal Year 2024
-
Q4 saw strong growth in paid customer projects, strategic agreements in medtech and defense, and a solid order book. Rights issue raised SEK 90 million to support scaling, with continued momentum expected in defense, energy, and medtech amid favorable market trends.
-
A modular 3D printing company is shifting from research to industrial markets, focusing on defense, energy, and med tech with unique capabilities in copper, tungsten, and titanium. Industrial engagements are rising, with major growth expected by 2030.
-
Q3 2024 saw strong growth in machine sales, a major medtech breakthrough, and a surge in paid feasibility studies. The order book reached nearly SEK 12 million, with robust demand in defense, energy, and medtech sectors.
-
Q2 2024 featured strong commercial and technical progress, highlighted by the first eMELT industrial machine installation and increased demand for tungsten and fusion applications. Financials showed modest sales, higher recurring revenues, and a strengthened cash position following a rights issue.